Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China · Delayed Price · Currency is CNY 27.27
0.00 (0.00%)
At close: May 6, 2026
SHE:301108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 77.48 | 77.27 | 19.46 | 115.2 | 140.97 | 220.05 |
Depreciation & Amortization | 50.91 | 50.91 | 46.75 | 39.06 | 34.41 | 30.81 |
Other Amortization | 3.68 | 3.68 | 0.95 | 0.12 | - | - |
Loss (Gain) From Sale of Assets | -0.36 | -0.36 | 0.03 | -0.32 | -1.15 | -0.29 |
Asset Writedown & Restructuring Costs | 10.55 | 10.55 | 17.49 | 10.51 | 11.46 | 0.42 |
Loss (Gain) From Sale of Investments | -16.44 | -16.44 | -13.31 | -29.13 | -12.93 | - |
Provision & Write-off of Bad Debts | 9.89 | 9.89 | 8.12 | -1.23 | 0.79 | 0.67 |
Other Operating Activities | 36.19 | 11.31 | -2.63 | -4.98 | -6.74 | 5.88 |
Change in Accounts Receivable | -182.88 | -182.88 | 21.05 | -29.87 | 36.39 | -6.34 |
Change in Inventory | -20.54 | -20.54 | -13.39 | -6.33 | 76.74 | -43.14 |
Change in Accounts Payable | 175.8 | 175.8 | -26.87 | -10.84 | -46.66 | -12.36 |
Change in Other Net Operating Assets | -11.84 | -11.84 | 13.69 | -1.68 | 65.52 | -3.26 |
Operating Cash Flow | 124.25 | 99.17 | 75.12 | 83.51 | 299.02 | 200.18 |
Operating Cash Flow Growth | 144.17% | 32.02% | -10.05% | -72.07% | 49.38% | 6.73% |
Capital Expenditures | -327.57 | -367.95 | -96.23 | -85.05 | -29.91 | -72.59 |
Sale of Property, Plant & Equipment | 2.46 | 2.75 | 0.62 | 0.38 | 0.35 | 0.12 |
Investment in Securities | -207.04 | 478.96 | -211.12 | -311.78 | -570 | - |
Other Investing Activities | 33.35 | 46.68 | 36.18 | 4.84 | 2.99 | -5 |
Investing Cash Flow | -498.79 | 160.44 | -270.56 | -391.61 | -596.57 | -77.47 |
Long-Term Debt Issued | - | 5.71 | - | - | - | - |
Long-Term Debt Repaid | - | -9.43 | -10.54 | -7.83 | - | -45 |
Net Debt Issued (Repaid) | 59.43 | -3.72 | -10.54 | -7.83 | - | -45 |
Issuance of Common Stock | - | - | - | - | - | 1,056 |
Repurchase of Common Stock | - | - | -20.06 | - | - | - |
Common Dividends Paid | -20.01 | -19.3 | -29.16 | -40.6 | -60.91 | -0.26 |
Other Financing Activities | -72.75 | -70.39 | 7.75 | 9.99 | 6.75 | -23.46 |
Financing Cash Flow | -33.33 | -93.4 | -52.01 | -38.45 | -54.16 | 987.26 |
Foreign Exchange Rate Adjustments | -7.21 | -2.58 | 1.64 | 0.53 | 0.61 | -3.62 |
Net Cash Flow | -415.07 | 163.63 | -245.81 | -346.02 | -351.11 | 1,106 |
Free Cash Flow | -203.31 | -268.78 | -21.11 | -1.54 | 269.1 | 127.59 |
Free Cash Flow Growth | - | - | - | - | 110.91% | 51.25% |
Free Cash Flow Margin | -24.19% | -34.82% | -3.86% | -0.25% | 40.37% | 12.96% |
Free Cash Flow Per Share | -1.66 | -2.37 | -0.18 | -0.01 | 2.37 | 1.46 |
Cash Income Tax Paid | - | -35.44 | -6.77 | 9.01 | 14.07 | -35.75 |
Levered Free Cash Flow | -432.73 | -277.68 | -49.34 | -4.2 | 146.82 | 14.34 |
Unlevered Free Cash Flow | -431.86 | -276.81 | -48.86 | -3.57 | 147.98 | 15.35 |
Change in Working Capital | -47.64 | -47.64 | -1.74 | -45.71 | 132.21 | -57.36 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.